- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
UMP.2: 14 residues within 4Å:- Chain A: R.345, C.490, H.491, Q.509, R.510, S.511, C.512, D.513, G.517, N.521, H.551, Y.553
- Chain B: R.470, R.471
12 PLIP interactions:9 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:D.513
- Hydrogen bonds: A:Q.509, A:S.511, A:D.513, A:N.521, A:N.521, A:H.551
- Salt bridges: A:R.345, A:R.510, B:R.470, B:R.471
- Water bridges: B:R.470
UMP.5: 14 residues within 4Å:- Chain A: R.470, R.471
- Chain B: R.345, C.490, H.491, Q.509, R.510, S.511, C.512, D.513, G.517, N.521, H.551, Y.553
13 PLIP interactions:10 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:Q.509, B:S.511, B:S.511, B:D.513, B:N.521, B:N.521, B:H.551, B:Y.553
- Salt bridges: B:R.345, B:R.510, A:R.470, A:R.471
- Water bridges: A:R.470
- 2 x U8I: 4-[3-[[2,4-bis(azanyl)-6-ethyl-pyrimidin-5-yl]methyl]phenyl]benzoic acid(Non-covalent)
U8I.3: 12 residues within 4Å:- Chain A: I.14, C.15, A.16, L.46, W.48, D.54, F.58, P.113, L.164, Y.170, T.185
- Ligands: NDP.1
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:L.46, A:W.48
- Hydrogen bonds: A:I.14, A:Y.170, A:T.185, A:T.185
- Salt bridges: A:D.54
- pi-Stacking: A:F.58
U8I.6: 14 residues within 4Å:- Chain B: I.14, C.15, A.16, L.46, W.48, D.54, M.55, F.58, P.113, F.116, L.164, Y.170, T.185
- Ligands: NDP.8
11 PLIP interactions:11 interactions with chain B- Hydrophobic interactions: B:A.16, B:L.46, B:W.48, B:F.58, B:F.58, B:L.164
- Hydrogen bonds: B:I.14, B:T.185, B:T.185
- Salt bridges: B:D.54
- pi-Stacking: B:F.116
- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.4: 7 residues within 4Å:- Chain A: V.453, Q.455, N.458, L.462, R.471
- Chain B: W.477, L.482
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.458
GOL.7: 5 residues within 4Å:- Chain A: W.477
- Chain B: V.453, N.458, L.462, R.471
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.458, B:R.471
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hoarau, M. et al., Discovery of rigid biphenyl Plasmodium falciparum DHFR inhibitors using a fragment linking strategy. Rsc Med Chem (2023)
- Release Date
- 2023-08-23
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
- 2 x U8I: 4-[3-[[2,4-bis(azanyl)-6-ethyl-pyrimidin-5-yl]methyl]phenyl]benzoic acid(Non-covalent)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hoarau, M. et al., Discovery of rigid biphenyl Plasmodium falciparum DHFR inhibitors using a fragment linking strategy. Rsc Med Chem (2023)
- Release Date
- 2023-08-23
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B